Time named President-elect Donald Trump its 2024 Person of the year early Thursday, hours before he was expected to ring the opening bell on Wall Street.
The Biden administration's extension of the COVID-19 emergency declaration until 2029 raises critical questions about accountability and the influence of pharmaceutical companies. Discover the implications of this controversial decision and the concerns it has sparked among critics.